Get started
SUN PHARMACEUTICAL IND LSUN PHARMACEUTICAL IND LSUN PHARMACEUTICAL IND L

SUN PHARMACEUTICAL IND L

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

SUNPHARMA trade ideas

SUNPHARMA Trading Within Weekly Demand ZoneSUNPHARMA is currently trading at ₹1575.4, within the weekly demand zone ranging from ₹1596.6 (baseHigh) to ₹1565.15 (baseLow), identified on 26th July 2024. This zone may act as a key support level, potentially attracting buyers. Investors should observe price action for signs of support holding or a potential reversal before making trading decisions. Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Please perform your own due diligence or consult a financial advisor before making any investment or trading decisions.
NSE:SUNPHARMALong
by rush12799
REVENUE RICH - SUN PHARMA LTD Sun Pharma Ltd is a leading pharmaceutical company revenue rich company and strong market presence. It is one of the top beneficiaries of various incentive schemes, which have bolstered its growth and profitability. Technical Analysis : The stock is currently forming a continuation pattern in 2 Hour Time Frame, indicating potential for further upward movement. Entry Point: ₹1830 Stop Loss: ₹1760 Target: Open/Mentioned Thanks, follow for more stocks recommendation.
NSE:SUNPHARMALong
by Vikrant_Mighty
Long The stock is approximately 56.9% undervalued relative to its intrinsic value of 4,137.50, suggesting a significant buying opportunity at the current price of 1,783. Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
NSE:SUNPHARMALong
by Shivkumar600
Amid HMVP Virus Concerns - SUN PHARMA Trade IdeaTrade Idea Explanation: The emergence of the HMVP virus in India has created a surge in demand for pharmaceutical products, particularly antiviral medications. Sun Pharmaceuticals, as one of India's largest and most diversified pharmaceutical companies, is well-positioned to benefit from this heightened demand. This technical trade idea aligns with the potential bullish sentiment driven by the company's fundamentals and the technical setup visible on the chart. Technical Setup: Rounding Bottom Pattern: A classic reversal pattern indicating accumulation and a potential trend reversal. The breakout from this pattern suggests a bullish continuation. Demand Zone: The price has shown a strong rebound from the demand zone at ₹1,840–₹1,850, reflecting significant buying interest. Sellers' Liquidity Zone: The price is approaching the sellers' liquidity zone near ₹1,920. A breakout above this level would indicate strength and open the door for higher targets. Volume Confirmation: The increasing volume at key levels validates the breakout and strengthens the bullish case. Trade Plan: Entry Levels: Enter long near ₹1,850. Alternatively, wait for a breakout above ₹1,860 for added confirmation. Targets: Target 1: ₹1,920 (sellers' liquidity zone). Target 2: ₹1,960 (next major resistance zone). Stop-Loss: Place a stop-loss below ₹1,820 to protect against downside risk. Risk-Reward Ratio: Minimum 1:2, ensuring an optimal risk-to-reward setup. Why SUN PHARMA? Sun Pharma has a well-diversified portfolio, including antivirals and other life-saving drugs. The HMVP virus outbreak could act as a catalyst for increased demand for its products. The technical setup aligns with a broader market opportunity, offering a strong risk-reward proposition for mid-term traders. Key Notes: Monitor news related to the HMVP virus and its impact on the pharmaceutical sector. Keep an eye on broader market sentiment and volume activity to validate the trade setup. Adjust targets and stop-loss levels if market conditions change.
NSE:SUNPHARMA
by MyT_Trader
1
Blue Chip Pharma: Fibo, Bullish Pattern and a good story...Pharma sector is one of the resilient sector in current market condition. 1. After fall for almost couple of months, its showing reversal signs. Made a double bottom at 38% of fib level. 2. After double bottom formation, consolidating sideways, even when Nifty was falling. This shows interest of big players and there accumulation. 3. Today, it has broken out of this sideways zone with higher volume and has confirmed the breakout. 4. Entry: 1841; SL: 1782 (3%); Target:1960 and then trailing profit with 9 EMA on day TF. Disclaimer: I have open cash position at this counter.
NSE:SUNPHARMA
by AbhayRege0703
SUNPHARMA - BREAKOUT RETEST or END of 5th?SUNPHARMA - CMP 1747 It appears that a 5 wave impulse from Covid lows (312) has ended at 1960 Primary and internal counts are marked in the chart If it is too early to predict/expect a larger retracement of the entire move, lets take one step at a time and look for the price action from May'23 lows.. The 5 wave impulse from 922 to 1960. Even here, the 5 waves are complete and the price is falling/retracing. Chart is attached here for reference If we expect a minimum of 50% retracement of this 5 wave impulse, then we are looking at 1440 levels Worst case, if you look at breakout retest (for those with bullish bias), then a dip down to 1640 cant be ruled out Price is trading below the cloud and Super trend on Daily TF Price is trading below all key EMAs.. and 200 EMA is next, placed at 1650 levels. Definitely not a place to go long.. Daily close above 1800 would be the invalidation level I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions.
NSE:SUNPHARMAShort
by Murthy_Santhosh
3